SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (2635)1/22/2001 8:00:58 PM
From: tom pope  Read Replies (1) | Respond to of 52153
 
Nice shooting on BGEN on Friday, Peter, especially as you were rewarded today with the MS news.



To: Biomaven who wrote (2635)1/22/2001 8:19:57 PM
From: jj_  Read Replies (1) | Respond to of 52153
 
Suzman
I was reading over the weekend about a HIV kit that was a approved in France and looked like it was going to be the standard in Europe. A Canadian company, VGIN. I'm not familiar with the company or the disease;what is the up side here.On the surface it read significant.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News